Genenta Science (GNTA)

• Market cap: $34M
• 1 day: -3.33%
• 5 days: 4.32%
• 1 month: -18.54%
• 3 months: -53.97%
• 6 months: -52.92%
• Year to date: -67.99%
• 1 year: -70.94%
• 5 years: -86.82%
• 10 years: -86.82%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 13